Fluoroquinolones and dysglycemia

Canadian Pharmacists Journal

Volumn 140, Issue 5, 2007, Pages 327-329

  Malak, Karina ^a   Naipaul, Rohini ^a   Ng, Mika ^a   Ruddock, Brent ^a  

^a Ontario Pharmacists' Association Drug Information and Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; GEMIFLOXACIN; GLIBENCLAMIDE; GLIMEPIRIDE; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REPAGLINIDE;

ARTICLE; CHRONIC BRONCHITIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MEDICAL INFORMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; SIDE EFFECT;

EID: 34848921517     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.3821/1913-701X(2007)140[327:FAD]2.0.CO;2     Document Type: Article

References (17)

1. Tailor SAN, Simor AE, Cornish W, et al. Analysis of spontaneous reports of hypoglycemia and hyperglycemia associated with marketed systemic fluoroquinolones made to the Canadian Adverse Drug Reaction Monitoring Program. Can J Hosp Pharm 2004;57(1):12-17.
2. Canadian Pharmacists Association. e-CPS [database on the Internet; cited May 15, 2007]. Ottawa: Canadian Pharmacists Association; 2007.
3. Owens RC Jr, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 2005;41(Suppl 2):S144-57.
4. Glucose abnormalities and fluoroquinolones. Pharmacist's Letter/Prescriber's Letter 2006;22(1):220109.
5. Catero M. Dysglycemia and fluoroquinolones: are you putting patients at risk? J Fam Pract 2007;56(2):101-7.
6. Tomita T, Onishi M, Sato E, et al. Gatifloxacin induces augmented insulin release and intracellular insulin depletion of pancreatic islet cells. Biol Pharm Bull 2007;30(4):644-7.
7. Yamada C, Nagashima K, Takahashi A, et al. Gatifloxacin acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis. Eur J Pharmacol 2006;553(1-3):67-72.
8. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003;27(suppl 2).
9. Hopkins M. Blood sugar highs & lows. Helping adults with diabetes manage acute hypo- and hyperglycemia. Diabetes Update 2006:S12-14,16,18, 19. [Special supplement to the April 2006 issue of Pharmacy Practice.] Available: www.pharmacygateway.ca/pdfs/2006/04/04-DIA-Glucose-06-web.pdf (accessed June 26, 2007).
10. American Diabetes Association. What is hyperosmolar hyperglycemic nonketotic syndrome (HHNS)? Available: www.diabetes.org/type-2-diabetes/ treatment-conditions/hhns.jsp (accessed June 25, 2007).
11. Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006;354(13):1352-61.
12. Graumlich JF, Habis S, Avelino RR, et al. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study. Pharmacotherapy 2005;25(10):1296-302.
13. Mohr JF, McKinnon PS, Peymann PJ, et al. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy 2005;25(10):1303-9.
14. American Society of Health-System Pharmacists. AHFS Drug Information (2007). In: STAT!Ref Online Electronic Medical Library [database on the Internet; cited May 15, 2007]. Bethesda: American Society of Health-System Pharmacists; 2007.
15. Hunt M. Levofloxacin: dysglycemia and liver disorders. Canadian Adverse Reaction Newsletter 2007;17(1):1-2. Available: www.hc-sc.gc.ca/dhp- mps/alt_formats/hpfb-dgpsa/pdf/medeff/carn-bcei_v17n1__e.pdf (accessed April 10, 2007).
16. Owens RC Jr. Fluoroquinolone-associated dysglycemias: a tale of two toxicities. Pharmacotherapy 2005;25(10):1291-5.
17. Health Canada. Health Canada Endorsed Important Safety Information on TEQUIN (gatifloxacin). May 12, 2006. Available: www.hc-sc.gc.ca/dhp-mps/medeff/ advisories-avis/prof/2006/tequin_2_hpc-cps_e.html (accessed April 4, 2007).